English
简体中文
Total: £ 56.28
Published Date: 2025-06-13 | Pages: 140 | Tables: 135 | Medical Devices & Consumables
In 2024, the global market size of Implantable Neurostimulation Devices was estimated to be worth US$ 5986 million and is forecast to reach approximately US$ 11700 million by 2031 with a CAGR of 10.2% during the forecast period 2025-2031.
Neurostimulation devices are implantable devices that help in the therapeutic activation of the nervous systems. These devices deliver electrical stimulation to the brain and nervous systems for the treatment of various types of neurological disorders such as pain, epilepsy, Parkinson's disease, depression, obsessive-compulsive disorder, dystonia, and tremors. These devices target specific areas of the brain or spinal cord by blocking the pain messages before they reach the brain.
The Implantable Neurostimulation Devices market is primarily driven by the rising prevalence of neurological disorders such as Parkinson's disease, epilepsy, chronic pain, and depression. As the global population ages, the incidence of these chronic conditions is increasing, creating a growing demand for effective and long-term treatment options. Implantable neurostimulators offer a promising solution for managing symptoms of these conditions, particularly for patients who have not responded to conventional therapies. Technological advancements in neurostimulation devices, such as more refined targeting mechanisms, smaller device sizes, and enhanced patient control, are also fueling market growth by improving treatment outcomes and patient satisfaction.
However, the market faces several challenges, including the high cost of implantable devices and the associated surgical procedures. These costs can limit accessibility, especially in low- and middle-income countries or healthcare systems with budget constraints. Additionally, while neurostimulators have shown positive results in treating various conditions, concerns remain regarding the long-term effectiveness, potential side effects, and device-related complications, such as battery life and the need for device replacements. The complexity of implantation and post-operative care also presents challenges for healthcare providers, requiring specialized training and resources, which may hinder broader adoption.
North America is the largest sales region of implantable neurostimulation devices, with market share nearly 42% in 2023. Europe is the second largest sales of implantable neurostimulation devices, enjoying market share nearly 29% in 2023. Medtronic, Boston Scientific, Abbott, LivaNova are the leading company, with the market share about 90%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Implantable Neurostimulation Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Implantable Neurostimulation Devices.
The Implantable Neurostimulation Devices market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Implantable Neurostimulation Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Implantable Neurostimulation Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Medtronic
Boston Scientific
Abbott
LivaNova
Nevro
Ruishenan Medical
Beijing Pins
Sceneray
Inspire Medical Systems
Nurotron
Segment by Type
Spinal Cord Stimulation (SCS)
Gastric Electric Stimulation (GES)
Deep Brain Stimulation (DBS)
Sacral Nerve Stimulation (SNS)
Vagus Nerve Stimulation (VNS)
Others
Segment by Application
Parkinson’s Disease
Epilepsy
Pain Management
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Implantable Neurostimulation Devices in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Implantable Neurostimulation Devices manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Implantable Neurostimulation Devices sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Implantable Neurostimulation Devices Product Introduction
1.2 Market by Type
1.2.1 Global Implantable Neurostimulation Devices Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Spinal Cord Stimulation (SCS)
1.2.3 Gastric Electric Stimulation (GES)
1.2.4 Deep Brain Stimulation (DBS)
1.2.5 Sacral Nerve Stimulation (SNS)
1.2.6 Vagus Nerve Stimulation (VNS)
1.2.7 Others
1.3 Market by Application
1.3.1 Global Implantable Neurostimulation Devices Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Parkinson’s Disease
1.3.3 Epilepsy
1.3.4 Pain Management
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Implantable Neurostimulation Devices Market Size Estimates and Forecasts
2.1.1 Global Implantable Neurostimulation Devices Revenue 2020-2031
2.1.2 Global Implantable Neurostimulation Devices Sales 2020-2031
2.2 Implantable Neurostimulation Devices Market Size by Region: 2024 Versus 2031
2.3 Implantable Neurostimulation Devices Sales by Region (2020-2031)
2.3.1 Global Implantable Neurostimulation Devices Sales by Region: 2020-2025
2.3.2 Global Implantable Neurostimulation Devices Sales Forecast by Region (2026-2031)
2.3.3 Global Implantable Neurostimulation Devices Sales Market Share by Region (2020-2031)
2.4 Implantable Neurostimulation Devices Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Implantable Neurostimulation Devices Revenue by Region: 2020-2025
2.4.2 Global Implantable Neurostimulation Devices Revenue Forecast by Region (2026-2031)
2.4.3 Global Implantable Neurostimulation Devices Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Implantable Neurostimulation Devices Sales by Type (2020-2031)
3.1.1.1 Global Implantable Neurostimulation Devices Sales Volume by Type (2020-2031)
3.1.1.2 Global Implantable Neurostimulation Devices Sales Market Share by Type (2020-2031)
3.1.2 Global Implantable Neurostimulation Devices Revenue by Type (2020-2031)
3.1.2.1 Global Implantable Neurostimulation Devices Revenue by Type (2020-2031)
3.1.2.2 Global Implantable Neurostimulation Devices Revenue Market Share by Type (2020-2031)
3.1.3 Implantable Neurostimulation Devices Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Implantable Neurostimulation Devices Sales by Application (2020-2031)
3.2.1.1 Global Implantable Neurostimulation Devices Sales Volume by Application (2020-2031)
3.2.1.2 Global Implantable Neurostimulation Devices Sales Market Share by Application (2020-2031)
3.2.2 Global Implantable Neurostimulation Devices Revenue by Application (2020-2031)
3.2.2.1 Global Implantable Neurostimulation Devices Revenue by Application (2020-2031)
3.2.2.2 Global Implantable Neurostimulation Devices Revenue Market Share by Application (2020-2031)
3.2.3 Implantable Neurostimulation Devices Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Spinal Cord Stimulation (SCS) of Implantable Neurostimulation Devices Revenue Market Share by Application
3.3.2 Gastric Electric Stimulation (GES) of Implantable Neurostimulation Devices Revenue Market Share by Application
3.3.3 Deep Brain Stimulation (DBS) of Implantable Neurostimulation Devices Revenue Market Share by Application
3.3.4 Sacral Nerve Stimulation (SNS) of Implantable Neurostimulation Devices Revenue Market Share by Application
3.3.5 Vagus Nerve Stimulation (VNS) of Implantable Neurostimulation Devices Revenue Market Share by Application
3.3.6 Others of Implantable Neurostimulation Devices Revenue Market Share by Application
4 Global Implantable Neurostimulation Devices by Manufacturers
4.1 Global Top Implantable Neurostimulation Devices Manufacturers by Sales (2020-2025)
4.1.1 Global Implantable Neurostimulation Devices Sales by Manufacturer (2020-2025)
4.1.2 Global Implantable Neurostimulation Devices Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Implantable Neurostimulation Devices Manufacturers by Revenue (2020-2025)
4.2.1 Global Implantable Neurostimulation Devices Revenue by Manufacturer (2020-2025)
4.2.2 Global Implantable Neurostimulation Devices Revenue Share by Manufacturer (2020-2025)
4.3 Global Implantable Neurostimulation Devices Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Implantable Neurostimulation Devices Manufacturers Covered: Ranking by Revenue
4.4.2 Global Implantable Neurostimulation Devices Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Implantable Neurostimulation Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Implantable Neurostimulation Devices Manufacturing Base Distribution, Product Type
4.5.1 Implantable Neurostimulation Devices Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Implantable Neurostimulation Devices Market
4.5.3 Manufacturers Implantable Neurostimulation Devices Product Type and Application
4.5.4 Spinal Cord Stimulation (SCS) Market Sales of Implantable Neurostimulation Devices by Manufacturer
4.5.5 Gastric Electric Stimulation (GES) Market Sales of Implantable Neurostimulation Devices by Manufacturer
4.5.6 Deep Brain Stimulation (DBS) Market Sales of Implantable Neurostimulation Devices by Manufacturer
4.5.7 Sacral Nerve Stimulation (SNS) Market Sales of Implantable Neurostimulation Devices by Manufacturer
4.5.8 Vagus Nerve Stimulation (VNS) Market Sales of Implantable Neurostimulation Devices by Manufacturer
4.5.9 Others Market Sales of Implantable Neurostimulation Devices by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Medtronic
5.1.1 Medtronic Company Information
5.1.2 Medtronic Description, Business Overview
5.1.3 Medtronic Implantable Neurostimulation Devices Products Offered
5.1.4 Medtronic Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Medtronic Implantable Neurostimulation Devices Sales by Product in 2024
5.1.6 Medtronic Implantable Neurostimulation Devices Sales by Application in 2024
5.1.7 Medtronic Implantable Neurostimulation Devices Sales by Geographic Area in 2024
5.1.8 Medtronic Recent Developments
5.2 Boston Scientific
5.2.1 Boston Scientific Company Information
5.2.2 Boston Scientific Description, Business Overview
5.2.3 Boston Scientific Implantable Neurostimulation Devices Products Offered
5.2.4 Boston Scientific Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Boston Scientific Implantable Neurostimulation Devices Sales by Product in 2024
5.2.6 Boston Scientific Implantable Neurostimulation Devices Sales by Application in 2024
5.2.7 Boston Scientific Implantable Neurostimulation Devices Sales by Geographic Area in 2024
5.2.8 Boston Scientific Recent Developments
5.3 Abbott
5.3.1 Abbott Company Information
5.3.2 Abbott Description, Business Overview
5.3.3 Abbott Implantable Neurostimulation Devices Products Offered
5.3.4 Abbott Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Abbott Implantable Neurostimulation Devices Sales by Product in 2024
5.3.6 Abbott Implantable Neurostimulation Devices Sales by Application in 2024
5.3.7 Abbott Implantable Neurostimulation Devices Sales by Geographic Area in 2024
5.3.8 Abbott Recent Developments
5.4 LivaNova
5.4.1 LivaNova Company Information
5.4.2 LivaNova Description, Business Overview
5.4.3 LivaNova Implantable Neurostimulation Devices Products Offered
5.4.4 LivaNova Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2020-2025)
5.4.5 LivaNova Implantable Neurostimulation Devices Sales by Product in 2024
5.4.6 LivaNova Implantable Neurostimulation Devices Sales by Application in 2024
5.4.7 LivaNova Implantable Neurostimulation Devices Sales by Geographic Area in 2024
5.4.8 LivaNova Recent Developments
5.5 Nevro
5.5.1 Nevro Company Information
5.5.2 Nevro Description, Business Overview
5.5.3 Nevro Implantable Neurostimulation Devices Products Offered
5.5.4 Nevro Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Nevro Implantable Neurostimulation Devices Sales by Product in 2024
5.5.6 Nevro Implantable Neurostimulation Devices Sales by Application in 2024
5.5.7 Nevro Implantable Neurostimulation Devices Sales by Geographic Area in 2024
5.5.8 Nevro Recent Developments
5.6 Ruishenan Medical
5.6.1 Ruishenan Medical Company Information
5.6.2 Ruishenan Medical Description, Business Overview
5.6.3 Ruishenan Medical Implantable Neurostimulation Devices Products Offered
5.6.4 Ruishenan Medical Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Ruishenan Medical Implantable Neurostimulation Devices Sales by Product in 2024
5.6.6 Ruishenan Medical Implantable Neurostimulation Devices Sales by Application in 2024
5.6.7 Ruishenan Medical Implantable Neurostimulation Devices Sales by Geographic Area in 2024
5.6.8 Ruishenan Medical Recent Developments
5.7 Beijing Pins
5.7.1 Beijing Pins Company Information
5.7.2 Beijing Pins Description, Business Overview
5.7.3 Beijing Pins Implantable Neurostimulation Devices Products Offered
5.7.4 Beijing Pins Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Beijing Pins Implantable Neurostimulation Devices Sales by Product in 2024
5.7.6 Beijing Pins Implantable Neurostimulation Devices Sales by Application in 2024
5.7.7 Beijing Pins Implantable Neurostimulation Devices Sales by Geographic Area in 2024
5.7.8 Beijing Pins Recent Developments
5.8 Sceneray
5.8.1 Sceneray Company Information
5.8.2 Sceneray Description, Business Overview
5.8.3 Sceneray Implantable Neurostimulation Devices Products Offered
5.8.4 Sceneray Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Sceneray Implantable Neurostimulation Devices Sales by Product in 2024
5.8.6 Sceneray Implantable Neurostimulation Devices Sales by Application in 2024
5.8.7 Sceneray Implantable Neurostimulation Devices Sales by Geographic Area in 2024
5.8.8 Sceneray Recent Developments
5.9 Inspire Medical Systems
5.9.1 Inspire Medical Systems Company Information
5.9.2 Inspire Medical Systems Description, Business Overview
5.9.3 Inspire Medical Systems Implantable Neurostimulation Devices Products Offered
5.9.4 Inspire Medical Systems Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Inspire Medical Systems Implantable Neurostimulation Devices Sales by Product in 2024
5.9.6 Inspire Medical Systems Implantable Neurostimulation Devices Sales by Application in 2024
5.9.7 Inspire Medical Systems Implantable Neurostimulation Devices Sales by Geographic Area in 2024
5.9.8 Inspire Medical Systems Recent Developments
5.10 Nurotron
5.10.1 Nurotron Company Information
5.10.2 Nurotron Description, Business Overview
5.10.3 Nurotron Implantable Neurostimulation Devices Products Offered
5.10.4 Nurotron Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Nurotron Implantable Neurostimulation Devices Sales by Product in 2024
5.10.6 Nurotron Implantable Neurostimulation Devices Sales by Application in 2024
5.10.7 Nurotron Implantable Neurostimulation Devices Sales by Geographic Area in 2024
5.10.8 Nurotron Recent Developments
6 North America
6.1 North America Implantable Neurostimulation Devices Market Size YoY Growth 2020-2031
6.2 North America Implantable Neurostimulation Devices Market Facts & Figures by Country
6.2.1 North America Implantable Neurostimulation Devices Sales by Country (2020-2031)
6.2.2 North America Implantable Neurostimulation Devices Revenue by Country (2020-2031)
6.3 North America Implantable Neurostimulation Devices Sales by Type (2020-2025)
6.4 North America Implantable Neurostimulation Devices Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Implantable Neurostimulation Devices Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Implantable Neurostimulation Devices Market Facts & Figures by Region
7.2.1 Asia-Pacific Implantable Neurostimulation Devices Sales by Region (2020-2031)
7.2.2 Asia-Pacific Implantable Neurostimulation Devices Revenue by Region (2020-2031)
7.3 Asia-Pacific Implantable Neurostimulation Devices Sales by Type (2020-2025)
7.4 Asia-Pacific Implantable Neurostimulation Devices Sales by Application (2020-2025)
8 Europe
8.1 Europe Implantable Neurostimulation Devices Market Size YoY Growth 2020-2031
8.2 Europe Implantable Neurostimulation Devices Market Facts & Figures by Country
8.2.1 Europe Implantable Neurostimulation Devices Sales by Country (2020-2031)
8.2.2 Europe Implantable Neurostimulation Devices Revenue by Country (2020-2031)
8.3 Europe Implantable Neurostimulation Devices Sales by Type (2020-2025)
8.4 Europe Implantable Neurostimulation Devices Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Implantable Neurostimulation Devices Market Size YoY Growth 2020-2031
9.2 Latin America Implantable Neurostimulation Devices Market Facts & Figures by Country
9.2.1 Latin America Implantable Neurostimulation Devices Sales by Country (2020-2031)
9.2.2 Latin America Implantable Neurostimulation Devices Revenue by Country (2020-2031)
9.3 Latin America Implantable Neurostimulation Devices Sales by Type (2020-2025)
9.4 Latin America Implantable Neurostimulation Devices Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Implantable Neurostimulation Devices Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Implantable Neurostimulation Devices Market Facts & Figures by Country
10.2.1 Middle East and Africa Implantable Neurostimulation Devices Sales by Country (2020-2031)
10.2.2 Middle East and Africa Implantable Neurostimulation Devices Revenue by Country (2020-2031)
10.3 Middle East and Africa Implantable Neurostimulation Devices Sales by Type (2020-2025)
10.4 Middle East and Africa Implantable Neurostimulation Devices Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Implantable Neurostimulation Devices Supply Chain Analysis
11.2 Implantable Neurostimulation Devices Key Raw Materials and Upstream Suppliers
11.3 Implantable Neurostimulation Devices Clients Analysis
11.4 Implantable Neurostimulation Devices Sales Channel and Sales Model Analysis
11.4.1 Implantable Neurostimulation Devices Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Implantable Neurostimulation Devices Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Implantable Neurostimulation Devices Distributors
12 Implantable Neurostimulation Devices Market Dynamics
12.1 Implantable Neurostimulation Devices Industry Trends
12.2 Implantable Neurostimulation Devices Market Drivers
12.3 Implantable Neurostimulation Devices Market Challenges
12.4 Implantable Neurostimulation Devices Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Implantable Neurostimulation Devices Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Implantable Neurostimulation Devices Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Implantable Neurostimulation Devices Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Implantable Neurostimulation Devices Sales by Region (2020-2025) & (Units)
Table 5. Global Implantable Neurostimulation Devices Sales Forecast by Region (2026-2031) & (Units)
Table 6. Global Implantable Neurostimulation Devices Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Implantable Neurostimulation Devices Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Implantable Neurostimulation Devices Sales Volume by Type (2020-2025) & (Units)
Table 9. Global Implantable Neurostimulation Devices Sales Volume by Type (2026-2031) & (Units)
Table 10. Global Implantable Neurostimulation Devices Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Implantable Neurostimulation Devices Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Implantable Neurostimulation Devices Sales Volume by Application (2020-2025) & (Units)
Table 13. Global Implantable Neurostimulation Devices Sales Volume by Application (2026-2031) & (Units)
Table 14. Global Implantable Neurostimulation Devices Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Implantable Neurostimulation Devices Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Implantable Neurostimulation Devices Sales by Manufacturer (2020-2025) & (Units)
Table 17. Global Implantable Neurostimulation Devices Sales Share by Manufacturer (2020-2025)
Table 18. Implantable Neurostimulation Devices Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Implantable Neurostimulation Devices Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Implantable Neurostimulation Devices Price (2020-2025) & (K USD/Unit)
Table 21. Ranking of Global Top Implantable Neurostimulation Devices Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Implantable Neurostimulation Devices Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Implantable Neurostimulation Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Implantable Neurostimulation Devices as of 2024)
Table 24. Implantable Neurostimulation Devices Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Implantable Neurostimulation Devices Market
Table 26. Manufacturers Implantable Neurostimulation Devices Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Medtronic Company Information
Table 29. Medtronic Description and Business Overview
Table 30. Medtronic Implantable Neurostimulation Devices Product
Table 31. Medtronic Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 32. Medtronic Sales Proportion of Implantable Neurostimulation Devices by Product in 2024
Table 33. Medtronic Sales Proportion of Implantable Neurostimulation Devices by Application in 2024
Table 34. Medtronic Sales Proportion of Implantable Neurostimulation Devices by Geographic Area in 2024
Table 35. Medtronic Recent Developments
Table 36. Boston Scientific Company Information
Table 37. Boston Scientific Description and Business Overview
Table 38. Boston Scientific Implantable Neurostimulation Devices Product
Table 39. Boston Scientific Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 40. Boston Scientific Sales Proportion of Implantable Neurostimulation Devices by Product in 2024
Table 41. Boston Scientific Sales Proportion of Implantable Neurostimulation Devices by Application in 2024
Table 42. Boston Scientific Sales Proportion of Implantable Neurostimulation Devices by Geographic Area in 2024
Table 43. Boston Scientific Recent Developments
Table 44. Abbott Company Information
Table 45. Abbott Description and Business Overview
Table 46. Abbott Implantable Neurostimulation Devices Product
Table 47. Abbott Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 48. Abbott Sales Proportion of Implantable Neurostimulation Devices by Product in 2024
Table 49. Abbott Sales Proportion of Implantable Neurostimulation Devices by Application in 2024
Table 50. Abbott Sales Proportion of Implantable Neurostimulation Devices by Geographic Area in 2024
Table 51. Abbott Recent Developments
Table 52. LivaNova Company Information
Table 53. LivaNova Description and Business Overview
Table 54. LivaNova Implantable Neurostimulation Devices Product
Table 55. LivaNova Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 56. LivaNova Sales Proportion of Implantable Neurostimulation Devices by Product in 2024
Table 57. LivaNova Sales Proportion of Implantable Neurostimulation Devices by Application in 2024
Table 58. LivaNova Sales Proportion of Implantable Neurostimulation Devices by Geographic Area in 2024
Table 59. LivaNova Recent Developments
Table 60. Nevro Company Information
Table 61. Nevro Description and Business Overview
Table 62. Nevro Implantable Neurostimulation Devices Product
Table 63. Nevro Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 64. Nevro Sales Proportion of Implantable Neurostimulation Devices by Product in 2024
Table 65. Nevro Sales Proportion of Implantable Neurostimulation Devices by Application in 2024
Table 66. Nevro Sales Proportion of Implantable Neurostimulation Devices by Geographic Area in 2024
Table 67. Nevro Recent Developments
Table 68. Ruishenan Medical Company Information
Table 69. Ruishenan Medical Description and Business Overview
Table 70. Ruishenan Medical Implantable Neurostimulation Devices Product
Table 71. Ruishenan Medical Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 72. Ruishenan Medical Sales Proportion of Implantable Neurostimulation Devices by Product in 2024
Table 73. Ruishenan Medical Sales Proportion of Implantable Neurostimulation Devices by Application in 2024
Table 74. Ruishenan Medical Sales Proportion of Implantable Neurostimulation Devices by Geographic Area in 2024
Table 75. Ruishenan Medical Recent Developments
Table 76. Beijing Pins Company Information
Table 77. Beijing Pins Description and Business Overview
Table 78. Beijing Pins Implantable Neurostimulation Devices Product
Table 79. Beijing Pins Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 80. Beijing Pins Sales Proportion of Implantable Neurostimulation Devices by Product in 2024
Table 81. Beijing Pins Sales Proportion of Implantable Neurostimulation Devices by Application in 2024
Table 82. Beijing Pins Sales Proportion of Implantable Neurostimulation Devices by Geographic Area in 2024
Table 83. Beijing Pins Recent Developments
Table 84. Sceneray Company Information
Table 85. Sceneray Description and Business Overview
Table 86. Sceneray Implantable Neurostimulation Devices Product
Table 87. Sceneray Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 88. Sceneray Sales Proportion of Implantable Neurostimulation Devices by Product in 2024
Table 89. Sceneray Sales Proportion of Implantable Neurostimulation Devices by Application in 2024
Table 90. Sceneray Sales Proportion of Implantable Neurostimulation Devices by Geographic Area in 2024
Table 91. Sceneray Recent Developments
Table 92. Inspire Medical Systems Company Information
Table 93. Inspire Medical Systems Description and Business Overview
Table 94. Inspire Medical Systems Implantable Neurostimulation Devices Product
Table 95. Inspire Medical Systems Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 96. Inspire Medical Systems Sales Proportion of Implantable Neurostimulation Devices by Product in 2024
Table 97. Inspire Medical Systems Sales Proportion of Implantable Neurostimulation Devices by Application in 2024
Table 98. Inspire Medical Systems Sales Proportion of Implantable Neurostimulation Devices by Geographic Area in 2024
Table 99. Inspire Medical Systems Recent Developments
Table 100. Nurotron Company Information
Table 101. Nurotron Description and Business Overview
Table 102. Nurotron Implantable Neurostimulation Devices Product
Table 103. Nurotron Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
Table 104. Nurotron Sales Proportion of Implantable Neurostimulation Devices by Product in 2024
Table 105. Nurotron Sales Proportion of Implantable Neurostimulation Devices by Application in 2024
Table 106. Nurotron Sales Proportion of Implantable Neurostimulation Devices by Geographic Area in 2024
Table 107. Nurotron Recent Developments
Table 108. North America Implantable Neurostimulation Devices Sales by Country (2020-2025) & (Units)
Table 109. North America Implantable Neurostimulation Devices Sales by Country (2026-2031) & (Units)
Table 110. North America Implantable Neurostimulation Devices Revenue by Country (2020-2025) & (US$ Million)
Table 111. North America Implantable Neurostimulation Devices Revenue by Country (2026-2031) & (US$ Million)
Table 112. North America Implantable Neurostimulation Devices Sales by Type (2020-2025) & (Units)
Table 113. North America Implantable Neurostimulation Devices Sales by Application (2020-2025) & (Units)
Table 114. Asia-Pacific Implantable Neurostimulation Devices Sales by Region (2020-2025) & (Units)
Table 115. Asia-Pacific Implantable Neurostimulation Devices Sales by Region (2026-2031) & (Units)
Table 116. Asia-Pacific Implantable Neurostimulation Devices Revenue by Region (2020-2025) & (US$ Million)
Table 117. Asia-Pacific Implantable Neurostimulation Devices Revenue by Region (2026-2031) & (US$ Million)
Table 118. Asia-Pacific Implantable Neurostimulation Devices Sales by Type (2020-2025) & (Units)
Table 119. Asia-Pacific Implantable Neurostimulation Devices Sales by Application (2020-2025) & (Units)
Table 120. Europe Implantable Neurostimulation Devices Sales by Country (2020-2025) & (Units)
Table 121. Europe Implantable Neurostimulation Devices Sales by Country (2026-2031) & (Units)
Table 122. Europe Implantable Neurostimulation Devices Revenue by Country (2020-2025) & (US$ Million)
Table 123. Europe Implantable Neurostimulation Devices Revenue by Country (2026-2031) & (US$ Million)
Table 124. Europe Implantable Neurostimulation Devices Sales by Type (2020-2025) & (Units)
Table 125. Europe Implantable Neurostimulation Devices Sales by Application (2020-2025) & (Units)
Table 126. Latin America Implantable Neurostimulation Devices Sales by Country (2020-2025) & (Units)
Table 127. Latin America Implantable Neurostimulation Devices Sales by Country (2026-2031) & (Units)
Table 128. Latin America Implantable Neurostimulation Devices Revenue by Country (2020-2025) & (US$ Million)
Table 129. Latin America Implantable Neurostimulation Devices Revenue by Country (2026-2031) & (US$ Million)
Table 130. Latin America Implantable Neurostimulation Devices Sales by Type (2020-2025) & (Units)
Table 131. Latin America Implantable Neurostimulation Devices Sales by Application (2020-2025) & (Units)
Table 132. Middle East and Africa Implantable Neurostimulation Devices Sales by Country (2020-2025) & (Units)
Table 133. Middle East and Africa Implantable Neurostimulation Devices Sales by Country (2026-2031) & (Units)
Table 134. Middle East and Africa Implantable Neurostimulation Devices Revenue by Country (2020-2025) & (US$ Million)
Table 135. Middle East and Africa Implantable Neurostimulation Devices Revenue by Country (2026-2031) & (US$ Million)
Table 136. Middle East and Africa Implantable Neurostimulation Devices Sales by Type (2020-2025) & (Units)
Table 137. Middle East and Africa Implantable Neurostimulation Devices Sales by Application (2020-2025) & (Units)
Table 138. Implantable Neurostimulation Devices Key Raw Materials, Industry Status and Trend
Table 139. Implantable Neurostimulation Devices Key Raw Materials and Upstream Suppliers
Table 140. Implantable Neurostimulation Devices Clients Status and Trend
Table 141. Implantable Neurostimulation Devices Typical Clients
Table 142. Implantable Neurostimulation Devices Distributors
Table 143. Implantable Neurostimulation Devices Market Trends
Table 144. Implantable Neurostimulation Devices Market Drivers
Table 145. Implantable Neurostimulation Devices Market Challenges
Table 146. Implantable Neurostimulation Devices Market Restraints
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
Table 150. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Implantable Neurostimulation Devices Product Picture
Figure 2. Global Implantable Neurostimulation Devices Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Implantable Neurostimulation Devices Sales Market Share by Type in 2024 & 2031
Figure 4. Spinal Cord Stimulation (SCS) Product Picture
Figure 5. Gastric Electric Stimulation (GES) Product Picture
Figure 6. Deep Brain Stimulation (DBS) Product Picture
Figure 7. Sacral Nerve Stimulation (SNS) Product Picture
Figure 8. Vagus Nerve Stimulation (VNS) Product Picture
Figure 9. Others Product Picture
Figure 10. Global Implantable Neurostimulation Devices Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 11. Global Implantable Neurostimulation Devices Sales Market Share by Application in 2024 & 2031
Figure 12. Parkinson’s Disease
Figure 13. Epilepsy
Figure 14. Pain Management
Figure 15. Other
Figure 16. Implantable Neurostimulation Devices Report Years Considered
Figure 17. Global Implantable Neurostimulation Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Implantable Neurostimulation Devices Market Size 2020-2031 (US$ Million)
Figure 19. Global Implantable Neurostimulation Devices Sales 2020-2031 (Units)
Figure 20. Global Implantable Neurostimulation Devices Sales Market Share Forecast by Region (2020-2031)
Figure 21. Global Implantable Neurostimulation Devices Revenue Market Share by Region (2020-2031)
Figure 22. Global Implantable Neurostimulation Devices Sales Market Share Forecast by Type (2020-2031)
Figure 23. Global Implantable Neurostimulation Devices Revenue Market Share Forecast by Type (2020-2031)
Figure 24. Implantable Neurostimulation Devices Average Selling Price (ASP) by Type (2020-2025) & (K USD/Unit)
Figure 25. Global Implantable Neurostimulation Devices Sales Market Share Forecast by Application (2020-2031)
Figure 26. Global Implantable Neurostimulation Devices Revenue Market Share Forecast by Application (2020-2031)
Figure 27. Implantable Neurostimulation Devices Average Selling Price (ASP) by Application (2020-2025) & (K USD/Unit)
Figure 28. Spinal Cord Stimulation (SCS) of Implantable Neurostimulation Devices Revenue Market Share by Application, 2024 VS 2031
Figure 29. Gastric Electric Stimulation (GES) of Implantable Neurostimulation Devices Revenue Market Share by Application, 2024 VS 2031
Figure 30. Deep Brain Stimulation (DBS) of Implantable Neurostimulation Devices Revenue Market Share by Application, 2024 VS 2031
Figure 31. Sacral Nerve Stimulation (SNS) of Implantable Neurostimulation Devices Revenue Market Share by Application, 2024 VS 2031
Figure 32. Vagus Nerve Stimulation (VNS) of Implantable Neurostimulation Devices Revenue Market Share by Application, 2024 VS 2031
Figure 33. Others of Implantable Neurostimulation Devices Revenue Market Share by Application, 2024 VS 2031
Figure 34. Global Implantable Neurostimulation Devices Sales Share by Manufacturer in 2024
Figure 35. Implantable Neurostimulation Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 36. Spinal Cord Stimulation (SCS) Market Sales Proportion by Manufacturer in 2024
Figure 37. Gastric Electric Stimulation (GES) Market Sales Proportion by Manufacturer in 2024
Figure 38. Deep Brain Stimulation (DBS) Market Sales Proportion by Manufacturer in 2024
Figure 39. Sacral Nerve Stimulation (SNS) Market Sales Proportion by Manufacturer in 2024
Figure 40. Vagus Nerve Stimulation (VNS) Market Sales Proportion by Manufacturer in 2024
Figure 41. Others Market Sales Proportion by Manufacturer in 2024
Figure 42. North America Implantable Neurostimulation Devices Revenue 2020-2031 (US$ Million)
Figure 43. North America Implantable Neurostimulation Devices Sales Market Share by Type (2020-2025)
Figure 44. North America Implantable Neurostimulation Devices Sales Market Share by Application (2020-2025)
Figure 45. Asia-Pacific Implantable Neurostimulation Devices Revenue 2020-2031 (US$ Million)
Figure 46. Asia-Pacific Implantable Neurostimulation Devices Sales Market Share by Region (2020-2031)
Figure 47. Asia-Pacific Implantable Neurostimulation Devices Revenue Market Share by Region (2020-2031)
Figure 48. Asia-Pacific Implantable Neurostimulation Devices Sales Market Share by Type (2020-2025)
Figure 49. Asia-Pacific Implantable Neurostimulation Devices Sales Market Share by Application (2020-2025)
Figure 50. Europe Implantable Neurostimulation Devices Revenue Growth Rate 2020-2031 (US$ Million)
Figure 51. Europe Implantable Neurostimulation Devices Sales Market Share by Country (2020-2031)
Figure 52. Europe Implantable Neurostimulation Devices Revenue Market Share by Country (2020-2031)
Figure 53. Europe Implantable Neurostimulation Devices Sales Market Share by Type (2020-2025)
Figure 54. Europe Implantable Neurostimulation Devices Sales Market Share by Application (2020-2025)
Figure 55. Latin America Implantable Neurostimulation Devices Revenue Growth Rate 2020-2031 (US$ Million)
Figure 56. Latin America Implantable Neurostimulation Devices Sales Market Share by Country (2020-2031)
Figure 57. Latin America Implantable Neurostimulation Devices Revenue Market Share by Country (2020-2025)
Figure 58. Latin America Implantable Neurostimulation Devices Sales Market Share by Type (2020-2025)
Figure 59. Latin America Implantable Neurostimulation Devices Sales Market Share by Application (2020-2025)
Figure 60. Middle East and Africa Implantable Neurostimulation Devices Revenue Growth Rate 2020-2031 (US$ Million)
Figure 61. Middle East and Africa Implantable Neurostimulation Devices Sales Market Share by Country (2020-2031)
Figure 62. Middle East and Africa Implantable Neurostimulation Devices Revenue Market Share by Country (2020-2031)
Figure 63. Middle East and Africa Implantable Neurostimulation Devices Sales Market Share by Type (2020-2025)
Figure 64. Middle East and Africa Implantable Neurostimulation Devices Sales Market Share by Application (2020-2025)
Figure 65. Implantable Neurostimulation Devices Supply Chain (Upstream and Downstream Market)
Figure 66. Global Production Market Share of Implantable Neurostimulation Devices Raw Materials by Region in 2024
Figure 67. Implantable Neurostimulation Devices Distribution Channels
Figure 68. Global Implantable Neurostimulation Devices Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 69. Global Implantable Neurostimulation Devices Percentage 2020-2031: Online Sales VS Offline Sales
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
